<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161396">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01835795</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 06251612.7.0000.0068</org_study_id>
    <nct_id>NCT01835795</nct_id>
  </id_info>
  <brief_title>Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain</brief_title>
  <official_title>Prospective, Comparative, Randomized Study of the Effectiveness of Shock Wave Treatment in Myofascial Pain Syndrome in Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of treatment of radial shockwave in
      myofascial pain syndrome in the lumbar region compared to placebo through questionnaires and
      imaging exams.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Evidence of pain relief by visual analogue scale (VAS) of radial extracorporeal shock waves in myofascial pain syndrome in the lumbar and gluteal region compared to placebo</measure>
    <time_frame>6 weeks after the last session of shockwave results will be measured</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The outcome will be assessed by Visual Analogue Scale (VAS)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Myofascial Pain Syndromes</condition>
  <condition>Myofascial Trigger Point</condition>
  <condition>Low Back Pain</condition>
  <condition>Lumbago</condition>
  <arm_group>
    <arm_group_label>Radial Extracorporeal Shock Wave</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radial Extracorporeal Shock Wave applicator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo applicator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radial Extracorporeal Shock Wave</intervention_name>
    <description>Radial Extracorporeal Shock Wave applicator use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 10 to 15 hertz frequency, 2 to 4 bar pressure</description>
    <arm_group_label>Radial Extracorporeal Shock Wave</arm_group_label>
    <other_name>Swiss DolorClast® CLASSIC applicator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo applicator, use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 10 to 15 hertz frequency, 2 to 4 bar pressure</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Swiss DolorClast® CLASSIC placebo applicator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presenting clinical complaints of lumbar and / or gluteal pains for 3 months or more

          -  Display pain of moderate to severe intensity: visual analogue scale (VAS)&gt; 4

          -  Diagnosis of myofascial pain syndrome in the lumbar and / or gluteal

          -  Authorize in writing the term of free and informed consent to participate in the
             study

          -  Availability of frequent attendance at hospital

        Exclusion Criteria:

          -  Organic or psychological disorders that contraindication participation of patients in
             study

          -  Metabolic, infectious, oncological or rheumatologic disorders

          -  Fibromyalgia

          -  Labor dispute

          -  Indication for surgery in column

          -  Contraindications to therapy of shock waves:

               -  Coagulopathy and / or anticoagulant

               -  Pregnancy

               -  Acute infection in soft tissue or bone

               -  Systemic Infections

               -  Presence of ulcers at treatment sites

               -  Presence of larger vessels or nerves at treatment sites

               -  Polyneuropathies

               -  Malignancies

               -  Cardiac arrhythmias or use of pacemaker

               -  Epilepsy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Kobayashi</last_name>
    <role>Principal Investigator</role>
    <affiliation>IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da USP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da USP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Kobayashi</last_name>
      <email>koba@globo.com</email>
    </contact>
    <investigator>
      <last_name>Ricardo Kobayashi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 18, 2013</lastchanged_date>
  <firstreceived_date>April 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ricardo Kobayashi</investigator_full_name>
    <investigator_title>Researcher and Collaborator of Pain Group</investigator_title>
  </responsible_party>
  <keyword>Myofascial Pain Syndromes</keyword>
  <keyword>Myofascial Trigger Point</keyword>
  <keyword>Low Back Pain</keyword>
  <keyword>Lumbago</keyword>
  <keyword>Shock Waves, High-Energy</keyword>
  <keyword>High-Energy Shock Waves</keyword>
  <keyword>Interdisciplinary Health Team</keyword>
  <keyword>Multidisciplinary Pain Centers</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
